ArticlePDF Available

Impact of Aortic Stenosis on Myofiber Stress: Translational Application of Left Ventricle-Aortic Coupling Simulation

Frontiers
Frontiers in Physiology
Authors:

Abstract and Figures

The severity of aortic stenosis (AS) has traditionally been graded by measuring hemodynamic parameters of transvalvular pressure gradient, ejection jet velocity, or estimating valve orifice area. Recent research has highlighted limitations of these criteria at effectively grading AS in presence of left ventricle (LV) dysfunction. We hypothesized that simulations coupling the aorta and LV could provide meaningful insight into myocardial biomechanical derangements that accompany AS. A realistic finite element model of the human heart with a coupled lumped-parameter circulatory system was used to simulate AS. Finite element analysis was performed with Abaqus FEA. An anisotropic hyperelastic model was assigned to LV passive properties, and a time-varying elastance function governed the LV active response. Global LV myofiber peak systolic stress (mean ± standard deviation) was 9.31 ± 10.33 kPa at baseline, 13.13 ± 10.29 kPa for moderate AS, and 16.18 ± 10.59 kPa for severe AS. Mean LV myofiber peak systolic strains were −22.40 ± 8.73%, −22.24 ± 8.91%, and −21.97 ± 9.18%, respectively. Stress was significantly elevated compared to baseline for moderate (p < 0.01) and severe AS (p < 0.001), and when compared to each other (p < 0.01). Ventricular regions that experienced the greatest systolic stress were (severe AS vs. baseline) basal inferior (39.87 vs. 30.02 kPa; p < 0.01), mid-anteroseptal (32.29 vs. 24.79 kPa; p < 0.001), and apex (27.99 vs. 23.52 kPa; p < 0.001). This data serves as a reference for future studies that will incorporate patient-specific ventricular geometries and material parameters, aiming to correlate LV biomechanics to AS severity.
Content may be subject to copyright.
fphys-11-574211 September 4, 2020 Time: 18:34 # 1
BRIEF RESEARCH REPORT
published: 08 September 2020
doi: 10.3389/fphys.2020.574211
Edited by:
Boyce Griffith,
University of North Carolina at Chapel
Hill, United States
Reviewed by:
Renee Miller,
King’s College London,
United Kingdom
Hao Gao,
University of Glasgow,
United Kingdom
*Correspondence:
Julius M. Guccione
Julius.Guccione@ucsf.edu
Present address:
Kevin L. Sack,
Division of Biomedical Engineering,
Department of Human Biology,
University of Cape Town, Cape Town,
South Africa
Specialty section:
This article was submitted to
Computational Physiology
and Medicine,
a section of the journal
Frontiers in Physiology
Received: 19 June 2020
Accepted: 19 August 2020
Published: 08 September 2020
Citation:
Wisneski AD, Wang Y, Deuse T,
Hill AC, Pasta S, Sack KL, Yao J and
Guccione JM (2020) Impact of Aortic
Stenosis on Myofiber Stress:
Translational Application of Left
Ventricle-Aortic Coupling Simulation.
Front. Physiol. 11:574211.
doi: 10.3389/fphys.2020.574211
Impact of Aortic Stenosis on
Myofiber Stress: Translational
Application of Left Ventricle-Aortic
Coupling Simulation
Andrew D. Wisneski1, Yunjie Wang2, Tobias Deuse1, Arthur C. Hill1, Salvatore Pasta3,
Kevin L. Sack4, Jiang Yao5and Julius M. Guccione1*
1Department of Surgery, University of California, San Francisco, San Francisco, CA, United States, 2Thornton Tomassetti
Lifesciences Division, Santa Clara, CA, United States, 3Department of Engineering, Universita degli Studi di Palermo,
Palermo, Italy, 4Cardiovascular Research Division, Medtronic Inc., Minneapolis, MN, United States, 5Dassault Systèmes
Simulia, Johnston, RI, United States
The severity of aortic stenosis (AS) has traditionally been graded by measuring
hemodynamic parameters of transvalvular pressure gradient, ejection jet velocity, or
estimating valve orifice area. Recent research has highlighted limitations of these
criteria at effectively grading AS in presence of left ventricle (LV) dysfunction. We
hypothesized that simulations coupling the aorta and LV could provide meaningful
insight into myocardial biomechanical derangements that accompany AS. A realistic
finite element model of the human heart with a coupled lumped-parameter circulatory
system was used to simulate AS. Finite element analysis was performed with Abaqus
FEA. An anisotropic hyperelastic model was assigned to LV passive properties, and a
time-varying elastance function governed the LV active response. Global LV myofiber
peak systolic stress (mean ±standard deviation) was 9.31 ±10.33 kPa at baseline,
13.13 ±10.29 kPa for moderate AS, and 16.18 ±10.59 kPa for severe AS. Mean
LV myofiber peak systolic strains were 22.40 ±8.73%, 22.24 ±8.91%, and
21.97 ±9.18%, respectively. Stress was significantly elevated compared to baseline
for moderate (p<0.01) and severe AS (p<0.001), and when compared to each
other (p<0.01). Ventricular regions that experienced the greatest systolic stress were
(severe AS vs. baseline) basal inferior (39.87 vs. 30.02 kPa; p<0.01), mid-anteroseptal
(32.29 vs. 24.79 kPa; p<0.001), and apex (27.99 vs. 23.52 kPa; p<0.001). This data
serves as a reference for future studies that will incorporate patient-specific ventricular
geometries and material parameters, aiming to correlate LV biomechanics to AS severity.
Keywords: aortic stenosis, finite element method, myofiber stress, ventricular function, realistic simulation,
ventricle-aortic coupling
INTRODUCTION
Aortic stenosis (AS) is the most prevalent valvular heart disease in the developed world (Lindman
et al., 2013;Go et al., 2014;Miura et al., 2015). Without treatment by surgical aortic valve
replacement or transcatheter aortic valve replacement, AS leads to irreversible left ventricle (LV)
remodeling and congestive heart failure, which have a poor prognosis (Lindman et al., 2013;
Frontiers in Physiology | www.frontiersin.org 1September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 2
Wisneski et al. Aortic Stenosis and Myofiber Stress
Go et al., 2014;Miura et al., 2015). Traditional means of
grading AS severity have predominantly relied on measuring
hemodynamically derived parameters such as transvalvular
pressure gradient, effective valve orifice area, and ejection blood
jet velocity (Nishimura et al., 2014;Baumgartner et al., 2017).
Recent research has brought to light limitations of these criteria
at effectively grading AS in the presence of LV dysfunction
coupled with decreased systemic arterial compliance, termed
“low-flow, low-gradient” AS (Hachicha et al., 2007;Pibarot and
Dumesnil, 2012;Tribouilloy et al., 2015). Additionally, the best
way to manage severe AS in asymptomatic patients remains
unclear, with only limited guiding evidence for the best course
of treatment (Wachtell, 2008;Nishimura et al., 2014;Carter-
Storch et al., 2019). Discordant outcomes have been reported
on the role of aortic valve replacement for these groups of
patients, highlighting the need to better diagnose and select
appropriate patients for treatment (Hachicha et al., 2007;Pibarot
and Dumesnil, 2012;Pibarot and Clavel, 2015;Tribouilloy et al.,
2015;Chadha et al., 2019).
Rather than being viewed as an isolated valve disease,
AS warrants a renewed understanding of its complex
pathophysiology wherein its detrimental effects on the
cardiovascular system are considered as derangements of
the LV, the aortic valve, and systemic vasculature together
(Briand et al., 2005). Advances in computational modeling
techniques now enable AS to be studied from a cardiovascular
systems perspective. LV-aortic coupling is a concept that
describes the inter-dependency of the LV and the aorta/systemic
blood vessels that impact cardiovascular function (Karabelas
et al., 2018;Shavik et al., 2018;Ikonomidis et al., 2019). Multi-
domain models of the human heart and circulatory system now
offer a complete mechanistic model of the ventricles, aortic
valve, and vasculature, making it ideally suited to investigate AS
(Baillargeon et al., 2014;Genet et al., 2014, 2016;Dabiri et al.,
2018;Sack et al., 2018b;Ghosh et al., 2020).
We believe that simulations of LV-aortic coupling with AS
will enable us to identify LV biomechanical parameters that are
prognostically significant markers of AS. Accordingly, as a first
step, we created isolated AS in an idealized human heart model
with the goal of gaining meaningful insight into the biomechanics
of the actual end-organ, the LV, which AS treatment seeks to
preserve. This investigation is one of the first of its kind to explore
this critical aspect of AS pathophysiology with the aid of powerful
computational simulation techniques.
METHODS
An idealized human heart model was generated from methods
described in Baillargeon et al. (2014) comprising solid
components, a finite element model, and a muscle fiber
model. It represents an average heart in a middle-aged individual
and can be altered to create diseased states.
Solid Model of the Ventricle
The solid model of the human heart portrays realistic anatomy of
four chambers, four valves, trabeculae in the ventricles, and great
vessels including the ascending aorta, the aortic arch, pulmonary
artery, and superior vena cava (Figure 1A). The LV finite element
model comprises approximately 120,000 tetrahedral elements.
Cardiac fiber orientation follows a rule-based approach from 60
degrees from epicardium to +60 degrees at the endocardium
(Dabiri et al., 2018;Sack et al., 2018a). Fiber and sheet directions
are interpolated and assigned to integration points of the finite
element model (Wong and Kuhl, 2014).
Constitutive Model Passive Material
Description
The ventricular material model passive response uses the
anisotropic hyperelastic formulation developed by Holzapfel and
Ogden, and has been widely published in many cardiac modeling
studies (Holzapfel and Ogden, 2009;Carrick et al., 2012;Sack
et al., 2016, 2018a). The deviatoric response is governed by the
following strain energy potential:
9dev =a
2bexp[b¯
I13)+X
i=f,s
ai
2biexp bi(¯
I4i1)21
+afs
2bfs
[exp(bfs¯
I2
8fs 1](1)
Eight material parameters a, b, af, bf,as, bs, afs, bfs, and four
strain invariants (¯
I1,¯
I4f,¯
I4s¯
I2
8fs)define Equation (1). For these
simulations, a= 3.354 kPa, b= 7.08, af= 2.501 kPa, bf= 5.34,
while the remaining parameters were set to null. The strain
invariants are derived from the isochoric right Cauchy-Green
tensor: ¯
C=¯
FT¯
F=J2/3C=J2/3FTF(2)
Fis the deformation gradient, Jis the determinant of the
deformation gradient, J=det (F)and ¯
Fis the isochoric part of
the deformation gradient where ¯
F=J1/3Fand det ¯
F=1.
The strain invariants can now be defined as:
¯
I1=tr ¯
C,¯
I4f=f0·¯
Cf0,¯
I4s=s0·¯
Cs0,¯
I8fs =f0·(¯
Cs0)
(3)
Terms f0and s0are orthogonal vectors in the fiber and sheet
direction in the reference configuration. The volumetric response
is governed by:
¯
9vol =1
D(J21)
2ln (J)(4)
where Jis the third deformation gradient invariant, and Dis the
multiple of the bulk modulus D=2
K.K was set to 1000 kPa.
This material model has been validated by Genet et al. for the
purposes of ventricular computational modeling (Baillargeon
et al., 2014;Genet et al., 2014).
Active Material Description
The active myocardial tissue response is represented as a
time-varying elastance model (Guccione and McCulloch, 1993;
Walker et al., 2005):
σaf t,E=Tmax
2
Ca2
0
Ca2
0+ECa2
50 E(1cos(ω(t,E))) (5)
Frontiers in Physiology | www.frontiersin.org 2September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 3
Wisneski et al. Aortic Stenosis and Myofiber Stress
FIGURE 1 | (A) Solid finite element model of the human heart model. (B) Schematic representation of lumped parameter model of circulatory system fluid links and
parameters. The term Raorta represents the aortic valve resistance parameter. Rmitral , mitral valve resistance; Carterial, systemic arterial compliance; Rsystem, systemic
arterial resistance; Cvenous, venous compliance; Rvenous , systemic venous compliance; Rtricuspid, tricuspid valve resistance; Rpulmonary, pulmonary valve resistance;
Cpulmonary, pulmonary vascular compliance; Rpulmonary–system , pulmonary vascular resistance. (C) Left ventricle pressure-volume loops for baseline, moderate aortic
stenosis, and severe aortic stenosis conditions. (D) Left ventricle-aortic time pressure curves over one cardiac cycle. The systolic gradient between the left ventricle
and aorta can be appreciated and serves as a marker of aortic stenosis severity.
with functions defined as:
ECa50 E=Ca0max
qeB(lEl01
(6)
ωt,E=πt
t0
when 0 t<t0(7a)
ωt,E=π
tt0+tr(lE)
tr
when t0tt0+tr(lE)(7b)
ωt,E=0 when t>t0+tr(lE)(7c)
trl=ml +b(7d)
lE=lrq2E+1 (7e)
Tmax is the maximum allowable active tension and is
multiplied by terms regulating calcium concentration and the
time course of the contraction. These two terms are dependent on
the sarcomere length l. This law has been used extensively in prior
published studies on ventricular mechanics (Walker et al., 2005;
Carrick et al., 2012;Sack et al., 2016, 2018b). Parameters were set
as follows: Tmax = 135.7 kPa, Ca0= 4.35 µmol/l, Ca0max = 4.35
µmol/l, m= 1.0489 s µm1,b= -1.429 s, B= 4.750 µm1,
l0= 1.58 µm. lris the sarcomere length in the unloaded state, and
was assumed to vary linearly from 1.78 µm at the endocardium
to 1.91 µm at the epicardium (Guccione et al., 1993;Rodriguez
et al., 1993;Walker et al., 2005).
The total stress (scalar form) in the sheet direction of the fiber
is represented by:
σs=σps +nσaf (8)
where active stress in the sheet direction, σs, is the sum of passive
stress, σps, and a portion of fiber direction stress, nσaf . The
parameter nis a scalar value less than 1.0 and represents the
interaction between adjacent muscle fibers; a value of n= 0.4 was
used (Walker et al., 2005).
Circulatory System, Aortic Stenosis, and
the Cardiac Cycle
The finite element model of the ventricles is coupled to lumped-
parameter models of the pulmonary and systemic circulatory
systems. This arrangement has been effective in other studies
to link the ventricles and systemic circulation (Sack et al., 2016,
2018a,b). A schematic of the connections is represented in
Frontiers in Physiology | www.frontiersin.org 3September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 4
Wisneski et al. Aortic Stenosis and Myofiber Stress
Figure 1B. Three simulation conditions were created: baseline
with a normal aortic valve, moderate aortic stenosis, and severe
aortic stenosis. AS was simulated by increasing the aortic valve
resistance parameter, confirmed by presence of the desired mean
systolic pressure gradient between the LV and the ascending
aorta. During the portion of systole when LV pressure exceeded
aortic pressure, the difference between the two was calculated at
each simulation timestep, and the average was taken to determine
the mean gradient across the aortic valve. The baseline aortic
valve resistance parameter was 1.0e-9 MPas/mm3with a mean
gradient of <2 mmHg. Moderate aortic stenosis was achieved
with resistance of 5.0e-9 MPas/mm3producing gradient of
20 mmHg, and severe aortic stenosis was created with 1.0e-
8 MPas/mm3with gradient of 40 mmHg.
The unloaded heart was initialized in a zero-stress state
obtained from iterative methods described by Sellier (2011)
and Rausch et al. (2017), based on loaded in vivo images.
At the start of the simulation, pressures within each cavity
were ramped from zero to physiologic values at 70% of
the diastole phase: right atrium 2 mmHg, right ventricle
2 mmHg, pulmonary artery 8 mmHg, left atrium 4 mmHg, left
ventricle 4 mmHg, aorta 80 mmHg, systemic arterial chamber
80 mmHg, systemic venous chamber 2 mmHg. Results for
analysis were obtained from the third cardiac cycle. Additional
resistance and compliance parameters in the circuit were
defined: systemic arterial resistance 1.4e+02 MPas/mm3,
systemic venous resistance 9.7e-1 MPas/mm3, tricuspid valve
resistance 2.5e-1 MPas/mm3, pulmonary valve resistance 9.7e-
1 MPas/mm3, pulmonary vascular resistance 1.1e+1 MPas/mm3,
the mitral valve resistance 2.3e+0 MPas/mm3, pulmonary
compliance 7.5e+6 mm3/MPa, systemic venous compliance
4.5e+7 mm3/MPa, and systemic arterial compliance
2.25e+6 mm3/MPa.
Cardiac cycles were simulated with Abaqus FEA (SimuliaTM,
Johnston, Rhode Island, United States) with an LV ejection
fraction (LVEF) of 60% for all three simulation conditions, with
end-diastolic volume of 136–138 ml. The same LV geometry
and mass were used across all three simulations for control
and represented a non-remodeled heart. A complete cardiac
cycle occurred over 0.7 s. The heart model is constrained in
space by fixed node sets at the cut planes of the aortic arch,
pulmonary trunk, and superior vena cava. An acceptable steady
state was achieved after running three consecutive cardiac cycles,
with further cycles producing <5% variation in the model’s
chamber pressures. LV myofiber stress and strain values were
obtained at end-diastole and peak systole (defined as the point
at which greatest LV pressure was generated). Data are expressed
as mean ±standard deviation. T-tests were used for statistical
comparison of continuous variables.
RESULTS
LV pressure-volume loops and LV-aorta pressure-time curves for
the different degrees of AS are shown in Figures 1C,D. Aortic
systolic pressure was 112–114 mmHg while diastolic pressure was
56–57 mmHg, representing a normal human physiologic range.
A mean systolic gradient of 20 mmHg between the LV and aorta
represented moderate AS. Conditions producing a mean systolic
gradient of 40 mmHg represented severe AS, and clinically would
serve as an indication for aortic valve replacement (Nishimura
et al., 2014;Baumgartner et al., 2017).
Global mean LV myofiber stress and strain values at end-
diastole and peak systole for each simulation condition are listed
in Table 1. Long-axis LV cross-sectional myofiber distribution
at end-diastole and peak systole are seen in Figure 2. The
endocardial regions harbor predominantly negative myofiber
stress at peak systole, a product of LV contraction physiology that
has been observed in other LV models (Genet et al., 2014;Sack
et al., 2016). Peak systolic myofiber stress increased progressively
with increasing degree of AS, whereas end-diastolic stress across
all conditions varied minimally with values <1.0 kPa. The mean
global LV myofiber stress was significantly different between
moderate AS and baseline (p<0.01) as well as between severe
AS and baseline (p<0.001).
Regional segmentation of the LV was performed in accordance
to the American Heart Association standardized myocardial
regions, creating 17 segments of LV myocardium based on
anatomic location and coronary perfusion territories (Cerqueira
et al., 2002). The mean myofiber stress of each of these segments
is shown in Figure 3. The range of peak systolic stress was 3.89
to 30.03 kPa for the baseline simulation, 4.81 to 34.79 kPa for
moderate AS, and 5.50 to 39.87 kPa for severe AS. Segments
that had the greatest peak myofiber stress from the basal, mid,
and apical regions were segment 3 (basal inferoseptal), segment 8
(mid-anteroseptal), and segment 17 (apex), and this finding was
consistent across all three simulation conditions.
DISCUSSION
Aortic stenosis has typically been graded by hemodynamic
parameters that can be measured on echocardiography: mean
pressure gradient across the valve, effective orifice area, and
peak blood jet velocity. However, a big limitation is that all
TABLE 1 | Global myofiber stress and strain in the left ventricle.
Simulation condition Myofiber stress Myofiber strain
End-diastole (kPa) Peak systole (kPa) End-diastole (%) Peak systole (%)
Baseline (no aortic stenosis) 0.31 ±1.36 9.31 ±10.33 +5.80 ±4.74 22.40 ±8.73
Moderate aortic stenosis 0.32 ±1.39 13.13 ±10.29 +5.94 ±4.82 22.24 ±8.91
Severe aortic stenosis 0.35 ±1.44 16.18 ±10.59 +6.16 ±4.90 21.97 ±9.18
Frontiers in Physiology | www.frontiersin.org 4September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 5
Wisneski et al. Aortic Stenosis and Myofiber Stress
FIGURE 2 | Long-axis cross-sectional views of the left ventricle demonstrating myofiber stress at end diastole (upper row) and peak systole (lower row) for each of
the three simulation conditions: baseline, moderate aortic stenosis, and severe aortic stenosis.
FIGURE 3 | Systolic myofiber stress for each of the 17 standardized
myocardial regions for each simulation condition: baseline, moderate aortic
stenosis, and severe aortic stenosis.
of these are derived from other specific parameters and are
flow-dependent. To better understand disease pathophysiology
and find new clinically useful markers, we created a realistic
human LV model with coupled circulatory system parameters,
and isolated moderate and severe AS. This is one of the first
computational studies to specifically investigate the impact of
AS on LV myofiber stress. In this model, moderate stenosis
provided peak LV myofiber stress 1.4 times greater than baseline,
and severe stenosis yielded peak stress of 1.7 times greater than
baseline. With all other parameters being held nearly equal
(LVEF, aortic blood pressure, LV geometry), it is an anticipated
physiologic response that higher degrees of afterload will increase
the amount of stress experienced by the LV.
LV systolic performance and ventricular stress have been
investigated as prognostic markers for AS patients (Wachtell,
2008). After all, chronic exposure to increased afterload triggers
remodeling, leading to LV hypertrophy and eventual dysfunction,
culminating in congestive heart failure. However, determining
stress values from clinical imaging alone presents substantial
limitations, such as not accounting for the myocardial material
properties, or permitting prediction about how wall stress
may change under different physiologic conditions or after
treatment of AS. One study calculated end-systolic wall stress
in 78 symptomatic and 91 asymptomatic patients and defined
severe AS by aortic valve area 1 cm2(Carter-Storch et al.,
2019). End-systolic wall stress was estimated by measuring LV
wall thickness from cardiac magnetic resonance images, and
LV end-systolic pressure from echocardiogram-derived mean
gradients. The results indicated that end-systolic wall stress was
significantly greater in symptomatic patients at 9.6 kPa than in the
asymptomatic patients at 7.6 kPa. Symptomatic patients also had
markers of more severe AS and LV dysfunction, with lower LVEF
and smaller indexed aortic valve areas. These results illustrate
the potential clinical utility of LV stress as a marker of disease
severity. Even with the aforementioned limitations, the authors
found significant differences in the stresses, indicative of the
critical role it has in the disease state. Differences between that
study and ours in terms of patient population and methods of
calculating wall stress make direct comparison of the numeric
results challenging, but theirs are in range of our computationally
derived myofiber stress results.
In a study of severe AS patients in which LV contractility
was correlated with overall survival, end-systolic wall stress
was greater in patients with LVEF <60% than in those with
LVEF 60% (9.48 kPa vs. 7.91 kPa; p<0.001) at the time
severe AS was diagnosed (Ito et al., 2020). Furthermore, patients
Frontiers in Physiology | www.frontiersin.org 5September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 6
Wisneski et al. Aortic Stenosis and Myofiber Stress
in the LVEF <60% group had significantly worse survival than
those in the LVEF 60% group. Classification of the patient
cohort by an end-systolic wall-stress threshold of 14.5 kPa, a
value estimated two standard deviations above the mean in
a population study by Aurigemma et al. (1994) also yielded
significantly worse survival in patients with >14.5 kPa end-
systolic wall stress. Six-year follow-up indicated cumulative
survivals of 20% (>14.5 kPa group) vs. 45% (14.5 kPa group).
This provides additional support for wall stress in the clinical
evaluation and prognostication of patients with AS (Aurigemma
et al., 1994;Ito et al., 2020).
The aforementioned studies were based on routine clinical
data and imaging available, with wall stress calculation techniques
based on Laplace’s Law. However, results derived from Laplace’s
Law are hindered by assumptions of uniform chamber geometry,
a relatively thin chamber thickness relative to radius, and do
not account for the myocardial material property. Additionally,
results derived using Laplace’s Law cannot provide detailed
information on transmural distribution of wall stress nor
local variations if focal ventricular pathology were to exist
(Zhang et al., 2011).
The ability to create patient-specific finite element models
would offer more accurate wall- stress results, as well as more
insight into the ventricular pathophysiology. One of the earliest
published finite element studies exploring the link between
aortic valve pathology and LV stress was done on aortic
insufficiency patients (Wollmuth et al., 2006). Patient-specific
LV geometries were obtained from cardiac magnetic resonance
imaging in patients with moderate-severe aortic insufficiency
before and after aortic valve replacement, as well as in control
volunteers without aortic valve disease. Maximum principal LV
end systolic stress was significantly elevated in patients with
aortic insufficiency before aortic valve replacement, relative to
controls (10.6 vs. 9.12 kPa; p<0.026). After aortic valve
replacement, LV end systolic stress decreased to 7.08 kPa. These
results help link the clinical benefit of aortic valve replacement
with LV biomechanics data, but are limited by the use of finite
element models with fairly few elements and assigning a linearly
elastic, isotropic material model to the myocardium. Aside from
the difference in the aortic valve disease studied by Wollmuth
et al., our LV model uses a highly refined mesh for the finite
element model, and a sophisticated myocardial material model
that accounts for microstructure, active, and passive properties.
The complexities of the myocardium need to be accounted for in
the material law in order to obtain the most accurate results.
Analysis of regional myocardial biomechanics is facilitated
with a solid, finite-element model. Our data from each of the
17 standardized myocardial segments reveals a range of stress
at peak systole, with anatomic regions each harboring regions
of localized peak stress. Examining how this ventricular stress
profile may vary among patients, or shift as disease progresses,
can offer a unique biomechanical profile for each patient. For
example, Jung et al. classified cardiac computed tomography
images of normal control patients and those with severe AS by
physical parameters associated with the 17 segments (Jung et al.,
2016). Two and three-dimensional parameters were found to
discriminate between the two patient groups, with the severe
AS group having greater LV wall thickness, segment mass, and
surface area. Among the segments, a range of values exists for
each parameter being evaluated. For instance, segment thickness
in AS patients ranged from 11.4 to 16.4 mm, whereas area ranged
8.3–13.7 cm2. Although differences in ventricular topography
and dimensions between the two groups are not surprising, the
study illustrates the added benefit of using regional segments to
perform more in-depth analysis of the LV.
In another study, the 17 segments were used to map
the distribution of myocardial fibrosis in AS patients by
analyzing gadolinium-contrast cardiac magnetic resonance
imaging (Weidemann et al., 2009). Patients with more severe
disease had fibrosis predominantly localized to the basal
segments. Although the impact of myocardial fibrosis on LV
myofiber stress remains a topic for further study, regional
segmentation offers better understanding of the pathologic
derangements occurring within the ventricle that are not
necessarily homogenously distributed. Global LV markers of
performance in conjunction with regional analysis can offer the
most in-depth understanding of LV derangements.
With advances in computational modeling techniques,
cardiovascular imaging, and a detailed understanding of
myocardial material properties, patient-specific models of clinical
utility are within reach and poised for more translational research
roles. Non-invasive means of determining parameters to tune
patient-specific models exist or are being perfected (Gray and
Pathmanathan, 2018;Dabiri et al., 2019;Mineroff et al., 2019;
Namasivayam et al., 2020). Enhanced constitutive myocardial
material models have been developed to account for presence
of fibrosis (Wang et al., 2016;Hasaballa et al., 2019). Ways to
integrate this data into clinical practice will first require larger
scale studies that have many patient-specific models. Clinical
and computational data needs to be correlated with patient
outcome, for example, whether the patient ultimately required
aortic valve replacement and how AS impacted LV function over
time. This correlation will help with the clinical validation of
computationally derived data and establish its place in clinical
decision-making algorithms.
Limitations
The primary limitation of this study is that our model represents
an idealized human heart geometry and simulates AS without
any LV remodeling. The material properties were based on
established, comprehensive models that describe normal
myocardial physiology, whereas AS is often a progressive
condition accompanied by a degree of LV remodeling
and fibrosis. Future studies with computational modeling
should incorporate patient-specific ventricular geometries,
myocardial material properties, and should address all possible
cardiovascular derangements in presence of AS.
CONCLUSION
In this study, we used a realistic human heart model with coupled
circulatory system to simulate AS and quantify the LV myofiber
stresses. This preliminary investigation used computational
Frontiers in Physiology | www.frontiersin.org 6September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 7
Wisneski et al. Aortic Stenosis and Myofiber Stress
methods to better assess the role of LV-aortic coupling in
the pathophysiology of aortic stenosis. Our goal is to apply
computationally derived data toward patient-specific assessment
of AS to guide management and intervention before irreversible
LV remodeling occurs.
DATA AVAILABILITY STATEMENT
The raw data supporting the conclusions of this article will be
made available by the authors, without undue reservation, to any
qualified researcher.
AUTHOR CONTRIBUTIONS
AW, YW, SP, and JG were involved in the conception, design
of the study, and analysis of the results. YW ran simulations
and provided data for analysis. JY and KS offered guidance on
the conditions for the computational simulations and assisted in
conducting the data analysis. AW, AH, TD, and JG were involved
in data analysis, interpretation of results, and the clinical concepts
of this study. All authors contributed to the article and approved
the submitted version.
FUNDING
This work was supported by the American Heart Association
post-doctoral fellowship, 18POST33960169 (AW).
ACKNOWLEDGMENTS
We thank Pamela Derish in the Department of Surgery,
University of California, San Francisco for proofreading
this manuscript.
REFERENCES
Aurigemma, G. P., Silver, K. H., McLaughlin, M., Mauser, J., and Gaasch, W. H.
(1994). Impact of chamber geometry and gender on left ventricular systolic
function in patients >60 years of age with aortic stenosis. Am. J. Cardiol. 74,
794–798. doi: 10.1016/0002-9149(94)90437-5
Baillargeon, B., Rebelo, N., Fox, D. D., Taylor, R. L., and Kuhl, E. (2014). The
living heart project: a robust and integrative simulator for human heart
function. Eur. J. Mech. A Solids 48, 38–47. doi: 10.1016/j.euromechsol.2014.
04.001
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., et al.
(2017). 2017 ESC/EACTS Guidelines for the management of valvular heart
disease. Eur. Heart J. 38, 2739–2791.
Briand, M., Dumesnil, J. G., Kadem, L., Tongue, A. G., Rieu, R., Garcia, D.,
et al. (2005). Reduced systemic arterial compliance impacts significantly on left
ventricular afterload and function in aortic stenosis: implications for diagnosis
and treatment. J. Am. Coll. Cardiol. 46, 291–298. doi: 10.1016/j.jacc.2004.
10.081
Carrick, R., Ge, L., Lee, L. C., Zhang, Z., Mishra, R., Axel, L., et al. (2012).
Patient-specific finite element-based analysis of ventricular myofiber stress after
Coapsys: importance of residual stress. Ann. Thorac. Surg. 93, 1964–1971. doi:
10.1016/j.athoracsur.2012.03.001
Carter-Storch, R., Moller, J. E., Christensen, N. L., Rasmussen, L. M., Pecini,
R., Søndergård, E., et al. (2019). End-systolic wall stress in aortic stenosis:
comparing symptomatic and asymptomatic patients. Open Heart 6:e001021.
doi: 10.1136/openhrt-2019- 001021
Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey,
W. K., et al. (2002). Standardized myocardial segmentation and nomenclature
for tomographic imaging of the heart. A statement for healthcare professionals
from the Cardiac Imaging Committee of the Council on Clinical Cardiology
of the American Heart Association. Circulation 105, 539–542. doi: 10.1161/
hc0402.102975
Chadha, G., Bohbot, Y., Rusinaru, D., Marechaux, S., and Tribouilloy, C. (2019).
Outcome of normal-flow low-gradient severe aortic stenosis with preserved left
ventricular ejection fraction: a propensity-matched study. J. Am. Heart Assoc.
8:e012301.
Dabiri, Y., Sack, K. L., Rebelo, N., Wang, P., Wang, Y., Choy, J. S., et al.
(2019). Method for calibration of left ventricle material properties using
three-dimensional echocardiography endocardial strains. J. Biomech. Eng.
141:091007.
Dabiri, Y., Sack, K. L., Shaul, S., Sengupta, P. P., and Guccione, J. M.
(2018). Relationship of transmural variations in myofiber contractility to left
ventricular ejection fraction: implications for modeling heart failure phenotype
with preserved ejection fraction. Front. Physiol. 9:1003. doi: 10.3389/fphys.2018.
01003
Genet, M., Lee, L. C., Baillargeon, B., Guccione, J. M., and Kuhl, E. (2016).
Modeling pathologies of diastolic and systolic heart failure. Ann. Biomed. Eng.
44, 112–127. doi: 10.1007/s10439-015-1351-2
Genet, M., Lee, L. C., Nguyen, R., Haraldsson, H., Acevedo-Bolton, G., Zhang,
Z., et al. (2014). Distribution of normal human left ventricular myofiber stress
at end diastole and end systole: a target for in silico design of heart failure
treatments. J. Appl. Physiol. 117, 142–152. doi: 10.1152/japplphysiol.00255.2014
Ghosh, R. P., Marom, G., Bianchi, M., D’Souza, K., Zietak, W., and Bluestein, D.
(2020). Numerical evaluation of transcatheter aortic valve performance during
heart beating and its post-deployment fluid-structure interaction analysis.
Biomech. Model. Mechanobiol. [Epub ahead of print] doi: 10.1007/s10237-020-
01304-9
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Blaha,
M. J., et al. (2014). Executive summary: heart disease and stroke statistics–
2014 update: a report from the American Heart Association. Circulation 129,
399–410.
Gray, R. A., and Pathmanathan, P. (2018). Patient-specific cardiovascular
computational modeling: diversity of personalization and challenges.
J. Cardiovasc. Transl. Res. 11, 80–88. doi: 10.1007/s12265-018- 9792-2
Guccione, J. M., and McCulloch, A. D. (1993). Mechanics of active contraction
in cardiac muscle: Part I–Constitutive relations for fiber stress that describe
deactivation. J. Biomech. Eng. 115, 72–81. doi: 10.1115/1.2895473
Guccione, J. M., Waldman, L. K., and McCulloch, A. D. (1993). Mechanics of active
contraction in cardiac muscle: Part II–Cylindrical models of the systolic left
ventricle. J. Biomech. Eng. 115, 82–90. doi: 10.1115/1.2895474
Hachicha, Z., Dumesnil, J. G., Bogaty, P., and Pibarot, P. (2007). Paradoxical low-
flow, low-gradient severe aortic stenosis despite preserved ejection fraction is
associated with higher afterload and reduced survival. Circulation 115, 2856–
2864. doi: 10.1161/circulationaha.106.668681
Hasaballa, A. I., Wang, V. Y., Sands, G. B., Wilson, A. J., Alistair, A. Y., LeGrice,
I. J., et al. (2019). Microstructurally motivated constitutive modeling of heart
failure mechanics. Biophys. J. 117, 2273–2286. doi: 10.1016/j.bpj.2019.09.038
Holzapfel, G. A., and Ogden, R. W. (2009). Constitutive modelling of passive
myocardium: a structurally based framework for material characterization.
Philos. Trans. A Math. Phys. Eng. Sci. 367, 3445–3475. doi: 10.1098/rsta.2009.
0091
Ikonomidis, I., Aboyans, V., Blacher, J., Brodmann, M., Brutsaert, D. L., Chirinos,
J. A., et al. (2019). The role of ventricular-arterial coupling in cardiac disease and
heart failure: assessment, clinical implications and therapeutic interventions.
A consensus document of the European Society of Cardiology Working
Group on Aorta & Peripheral Vascular Diseases, European Association of
Frontiers in Physiology | www.frontiersin.org 7September 2020 | Volume 11 | Article 574211
fphys-11-574211 September 4, 2020 Time: 18:34 # 8
Wisneski et al. Aortic Stenosis and Myofiber Stress
Cardiovascular Imaging, and Heart Failure Association. Eur. J. Heart Fail. 21,
402–424. doi: 10.1002/ejhf.1436
Ito, S., Pislaru, C., Miranda, W. R., Nkomo, V. T., Connolly, H. M., Pislaru, S. V.,
et al. (2020). Left ventricular contractility and wall stress in patients with aortic
stenosis with preserved or reduced ejection fraction. JACC Cardiovasc. Imaging
13(2 Pt 1), 357–369. doi: 10.1016/j.jcmg.2019.01.009
Jung, J., Kim, Y. H., Kim, N., and Yang, D. H. (2016). Patient-specific 17-segment
myocardial modeling on a bull’s eye map. J. Appl. Clin. Med. Phys. 17, 453–465.
doi: 10.1120/jacmp.v17i5.6237
Karabelas, E., Gsell, M. A. F., Augustin, C. M., Marx, L., Neic, A., Prassl, A. J.,
et al. (2018). Towards a computational framework for modeling the impact
of aortic coarctations upon left ventricular load. Front. Physiol. 9:538. doi:
10.3389/fphys.2018.00538
Lindman, B. R., Bonow, R. O., and Otto, C. M. (2013). Current management
of calcific aortic stenosis. Circ. Res. 113, 223–237. doi: 10.1001/jama.1963.
03700100151094
Mineroff, J., McCulloch, A. D., Krummen, D., Ganapathysubramanian, B., and
Krishnamurthy, A. (2019). Optimization framework for patient-specific cardiac
modeling. Cardiovasc. Eng. Technol. 10, 553–567. doi: 10.1007/s13239-019-
00428-z
Miura, S., Arita, T., Kumamaru, H., Domei, T., Yamaji, K., Soga, Y., et al. (2015).
Causes of death and mortality and evaluation of prognostic factors in patients
with severe aortic stenosis in an aging society. J. Cardiol. 65, 353–359. doi:
10.1016/j.jjcc.2015.02.011
Namasivayam, M., Adji, A., Lin, L., Hayward, C. S., Feneley, M. P., O’Rourke,
M. F., et al. (2020). Non-invasive quantification of ventricular contractility,
arterial elastic function and ventriculo-arterial coupling from a single diagnostic
encounter using simultaneous arterial tonometry and magnetic resonance
imaging. Cardiovasc. Eng. Technol. 11, 283–294. doi: 10.1007/s13239-020-
00462-2
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P. III,
Guyton, R. A., et al. (2014). 2014 AHA/ACC guideline for the management
of patients with valvular heart disease: a report of the american college
of cardiology/american heart association task force on practice guidelines.
Circulation 129, e521–e643.
Pibarot, P., and Clavel, M. A. (2015). Management of paradoxical low-flow, low-
gradient aortic stenosis: need for an integrated approach, including assessment
of symptoms, hypertension, and stenosis severity. J. Am. Coll. Cardiol. 65,
67–71. doi: 10.1016/j.jacc.2014.10.030
Pibarot, P., and Dumesnil, J. G. (2012). Low-flow, low-gradient aortic stenosis with
normal and depressed left ventricular ejection fraction. J. Am. Coll. Cardiol. 60,
1845–1853. doi: 10.1016/j.jacc.2012.06.051
Rausch, M. K., Genet, M., and Humphrey, J. D. (2017). An augmented iterative
method for identifying a stress-free reference configuration in image-based
biomechanical modeling. J. Biomech. 58, 227–231. doi: 10.1016/j.jbiomech.
2017.04.021
Rodriguez, E. K., Omens, J. H., Waldman, L. K., and McCulloch, A. D. (1993).
Effect of residual stress on transmural sarcomere length distributions in rat left
ventricle. Am. J. Physiol. 264(4 Pt 2), H1048–H1056.
Sack, K. L., Baillargeon, B., Acevedo-Bolton, G., Genet, M., Rebelo, N., Kuhl, E.,
et al. (2016). Partial LVAD restores ventricular outputs and normalizes LV but
not RV stress distributions in the acutely failing heart in silico. Int. J. Artif.
Organs 39, 421–430. doi: 10.5301/ijao.5000520
Sack, K. L., Aliotta, E., Ennis, D. B., Choy, J. S., Kassab, G. S., Guccione,
J. M., et al. (2018a). Construction and validation of subject-specific
biventricular finite-element models of healthy and failing swine hearts
from high-resolution DT-MRI. Front. Physiol. 9:539. doi: 10.3389/fphys.2018.
00539
Sack, K. L., Dabiri, Y., Franz, T., Solomon, S. D., Burkhoff, D., and Guccione,
J. M. (2018b). Investigating the role of interventricular interdependence in
development of right heart dysfunction during LVAD support: a patient-specific
methods-based approach. Front. Physiol. 9:520. doi: 10.3389/fphys.2018.
00520
Sellier, M. (2011). An interative method for the inverse elasto-static problem.
J. Fluids Struct. 27, 1461–1470. doi: 10.1016/j.jfluidstructs.2011.08.002
Shavik, S. M., Jiang, Z., Baek, S., and Lee, L. C. (2018). High spatial resolution multi-
organ finite element modeling of ventricular-arterial coupling. Front. Physiol.
9:119. doi: 10.3389/fphys.2018.00119
Tribouilloy, C., Rusinaru, D., Marechaux, S., Castel, A. L., Debry, N., Maizel,
J., et al. (2015). Low-gradient, low-flow severe aortic stenosis with preserved
left ventricular ejection fraction: characteristics, outcome, and implications for
surgery. J. Am. Coll. Cardiol. 65, 55–66.
Wachtell, K. (2008). Left ventricular systolic performance in asymptomatic aortic
stenosis. Eur. Heart J. Suppl. 10, E16–E22.
Walker, J. C., Ratcliffe, M. B., Zhang, P., Wallace, A. W., Fata, B., Hsu, E. W., et al.
(2005). MRI-based finite-element analysis of left ventricular aneurysm. Am. J.
Physiol. Heart Circ. Physiol. 289, H692–H700.
Wang, V. Y., Niestrawska, J. A., Wilson, A. J., Sands, G. B., Young, A. A., LeGrice,
I. J., et al. (2016). Image-drive constitutive modeling of myocardial fibrosis.
Int. J. Comp. Meth. Eng. Sci. Mech. 17, 211–221. doi: 10.1080/15502287.2015.
1082675
Weidemann, F., Herrmann, S., Störk, S., Niemann, M., Frantz, S., Lange, V.,
et al. (2009). Impact of myocardial fibrosis in patients with symptomatic severe
aortic stenosis. Circulation 120, 577–584. doi: 10.1161/circulationaha.108.
847772
Wollmuth, J. R., Bree, D. R., Cupps, B. P., Krock, M. D., Pomerantz, B. J., Pasque,
R. P., et al. (2006). Left ventricular wall stress in patients with severe aortic
insufficiency with finite element analysis. Ann. Thorac. Surg. 82, 840–846. doi:
10.1016/j.athoracsur.2006.03.100
Wong, J., and Kuhl, E. (2014). Generating fibre orientation maps in human heart
models using Poisson interpolation. Comput. Methods Biomech. Biomed. Engin.
17, 1217–1226. doi: 10.1080/10255842.2012.739167
Zhang, Z., Tendulkar, A., Sun, K., Saloner, D. A., Wallace, A. W., Ge, L.,
et al. (2011). Comparison of the Young-Laplace law and finite element based
calculation of ventricular wall stress: implications for postinfarct and surgical
ventricular remodeling. Ann. Thorac. Surg. 91, 150–156. doi: 10.1016/j.
athoracsur.2010.06.132
Conflict of Interest: YW was employed by the company Thornton Tomassetti
Lifesciences Division. KS is currently employed by the company Medtronic Inc. JY
was employed by the company Dassault Systemes Simulia Corp.
The remaining authors declare that the research was conducted in the absence of
any commercial or financial relationships that could be construed as a potential
conflict of interest.
The reviewer HG declared a past co-authorship with one of the authors JY to the
handling editor.
Copyright © 2020 Wisneski, Wang, Deuse, Hill, Pasta, Sack, Yao and Guccione.
This is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) and the copyright owner(s) are credited
and that the original publication in this journal is cited, in accordance with accepted
academic practice. No use, distribution or reproduction is permitted which does not
comply with these terms.
Frontiers in Physiology | www.frontiersin.org 8September 2020 | Volume 11 | Article 574211
... A geometric model of the left heart was derived from the two-chamber Living Heart Model (LHM) developed by the SIMULIA Living Heart Project within the 3D Experience platform (3D Experience R2023, Dassault Systèmes, Providence, RI, USA) [16,17]. This model accurately depicts an adult male heart with normal physiological function, as shown in Figure 1A. ...
... The biomechanical behavior of the left heart was considered with respect to both passive cardiac properties and active contraction originating from the myocardium. The passive material behavior was simulated using the anisotropic hyperelastic constitutive model developed by Ogden and Holzapfel [18], which has been widely used in many cardiac in silico analyses [17,19,20]. The deviatoric response was governed by the following strain energy potential: ...
Article
Full-text available
Mitral valve regurgitation is a common heart valve disorder associated with significant morbidity and mortality. Transcatheter mitral valve repair using the MitraClip device has emerged as a safe and effective alternative for patients unsuitable for conventional surgery. However, the structural and hemodynamic implications of MitraClip implantation in the left ventricle have not been extensively explored. This study aimed to assess the structural and hemodynamic performance of the MitraClip device using a high-fidelity model of the human heart, specifically focusing on a healthy mitral valve geometry. The implantation of the MitraClip device was simulated using the finite element method for structural analysis and the lattice Boltzmann method for computational flow analysis. MitraClip implantation induced geometrical changes in the mitral valve, resulting in local maxima of principal stress in the valve leaflet regions constrained by the device. Hemodynamic assessment revealed slow-moving nested helical flow near the left ventricular wall and high flow velocities in the apex regions. Vorticity analysis indicated abnormal hemodynamic conditions induced by the double-orifice area configuration of the mitral valve after MitraClip implantation. By predicting possible adverse events and complications in a patient-specific manner, computational modeling supports evidence-based decision making and enhances the overall effectiveness and safety of transcatheter mitral valve repairs.
... The CAS-eHLHS heart has drastically different biomechanical characteristics from the healthy heart, the FAV intervention is essentially a mechanical intervention in nature, and the heart is likely to be mechanosensitive in its growth, where abnormal biomechanics may play a significant role in the progression to malformation. Cardiac finite element (FE) computational modelling is a good approach for investigating myocardial biomechanics and has been very useful in improving our understanding of a multitude of heart diseases in the past (Dewan et al., 2017;Ong et al., 2020;Shavik et al., 2021;Wisneski et al., 2020). For example, we have previously used such a model to elucidate the effects of how various CAS-eHLHS characteristics impact cardiac function and biomechanics (Ong et al., 2020). ...
Article
Full-text available
Fetal critical aortic stenosis with evolving hypoplastic left heart syndrome (CAS‐eHLHS) causes biomechanical and functional aberrations, leading to a high risk of progression to hypoplastic left heart syndrome (HLHS) at birth. Fetal aortic valvuloplasty (FAV) can resolve outflow obstruction and may reduce progression risk. However, it is currently difficult to accurately predict which patients will respond to the intervention and become functionally biventricular (BV) at birth, as opposed to becoming functionally univentricular (UV). This prediction is important for patient selection, parental counselling, and surgical planning. Therefore, we investigated whether biomechanics parameters from pre‐FAV image‐based computations could robustly distinguish between CAS‐eHLHS cases with BV or UV outcomes in a retrospective cohort. To do so we performed image‐based finite element biomechanics modelling of nine CAS‐eHLHS cases undergoing intervention and six healthy fetal control hearts, and found that a biomechanical parameter, peak systolic myofibre stress, showed a uniquely large difference between BV and UV cases, which had a larger magnitude effect than echocardiography parameters. A simplified equation was derived for quick and easy estimation of myofibre stress from echo measurements via principal component analysis. When tested on a retrospective cohort of 37 CAS‐eHLHS cases, the parameter outperformed other parameters in predicting UV versus BV outcomes, and thus has a high potential of improving outcome predictions, if incorporated into patient selection procedures. Physiologically, high myocardial stresses likely indicate a healthier myocardium that can withstand high stresses and resist pathological remodelling, which can explain why it is a good predictor of BV outcomes. image Key points Predicting the morphological birth outcomes (univentricular versus biventricular) of fetal aortic valvuloplasty for fetal aortic stenosis with evolving HLHS is important for accurate patient selection, parental counselling and management decisions. Computational simulations show that a biomechanics parameter, pre‐intervention peak systolic myofibre stress, is uniquely robust in distinguishing between such outcomes, outperforming all echo parameters. An empirical equation was developed to quickly compute peak systolic myofibre stress from routine echo measurements and was the best predictor of outcomes among a wide range of parameters tested.
... Using a solid finite element model of the heart with AS, Wisneski et al. in their study described the highest systolic strain in the area of the basal IVS segment [18]. It can be assumed that in patients with severe AS, the IVS is the most burdened area during pressure overload. ...
Article
Full-text available
At the present time, right ventricular function in patients with aortic stenosis is insufficiently taken into account in the decision-making process of aortic valve replacement. The aim of our study was to evaluate significance of right ventricular dysfunction in patients with severe aortic stenosis by modern 3D echocardiographic methods. This is prospective analysis of 68 patients with severe high and low-gradient aortic stenosis. We evaluated function of left and right ventricle on the basis of 3D reconstruction. Enddiastolic, endsystolic volumes, ejection fraction and stroke volumes of both chambers were assessed. There were more patients with right ventricular dysfunction in low-gradient group (RVEF < 45%) than in the high-gradient group (63.6% vs 39%, p = 0.02). Low-gradient patients had worse right ventricular function than high-gradient patients (RVEF 36% vs 46%, p = 0.02). There wasn’t any significant correlation between the right ventricular dysfunction and pulmonary hypertension (r = − 0.25, p = 0.036). There was significant correlation between left and right ejection fraction (r = 0.78, p < 0.0001). Multiple regression analysis revealed that the only predictor of right ventricular function is the left ventricular function. According to our results we can state that right ventricular dysfunction is more common in patients with low-gradient than in high-gradient aortic stenosis and the only predictor of right ventricular dysfunction is left ventricular dysfunction, probably based on ventriculo-ventricular interaction. Pulmonary hypertension in patients with severe AS does not predict right ventricular dysfunction.
... The computational cardiac biomechanics model was adapted from the Living Heart Human Project (version 2.1, Simulia, Dassault Systèmes) (Baillargeon et al., 2014), previously used for biomechanical simulation studies by (Genet et al., 2014;Sack et al., 2016a,b;Genet et al., 2016;Sack et al., 2018b,a;Peirlinck et al., 2018;Dabiri et al., 2018;Sahli Costabal et al., 2019;Dabiri et al., 2019b,a;Peirlinck et al., 2021;Guan et al., 2020;Dabiri et al., 2020;Wisneski et al., 2020;Heidari et al., 2022;St. Pierre et al., 2022). ...
Article
Full-text available
Simulations of cardiac electrophysiology and mechanics have been reported to be sensitive to the microstructural anisotropy of the myocardium. Consequently, a personalized representation of cardiac microstructure is a crucial component of accurate, personalized cardiac biomechanical models. In-vivo cardiac Diffusion Tensor Imaging (cDTI) is a non-invasive magnetic resonance imaging technique capable of probing the heart’s microstructure. Being a rather novel technique, issues such as low resolution, signal-to noise ratio, and spatial coverage are currently limiting factors. We outline four interpolation techniques with varying degrees of data fidelity, different amounts of smoothing strength, and varying representation error to bridge the gap between the sparse in-vivo data and the model, requiring a 3D representation of microstructure across the myocardium. We provide a workflow to incorporate in-vivo myofiber orientation into a left ventricular model and demonstrate that personalized modelling based on fiber orientations from in-vivo cDTI data is feasible. The interpolation error is correlated with a trend in personalized parameters and simulated physiological parameters, strains, and ventricular twist. This trend in simulation results is consistent across material parameter settings and therefore corresponds to a bias introduced by the interpolation method. This study suggests that using a tensor interpolation approach to personalize microstructure with in-vivo cDTI data, reduces the fiber uncertainty and thereby the bias in the simulation results.
... Numerical analysis enables non-invasive mechanical assessment of the cardiovascular system (Chandran, 2010;Niederer et al., 2011;Votta et al., 2013;Sahli Costabal et al., 2018;Wisneski et al., 2020;Cutugno et al., 2021). In recent years, models have been developed to investigate the impact of HFpEF on heart function (Poh et al., 2012;Adeniran et al., 2015;Dabiri et al., 2018;Escher et al., 2020). ...
Article
Full-text available
A substantial proportion of heart failure patients have a preserved left ventricular (LV) ejection fraction (HFpEF). This condition carries a high burden of morbidity and mortality and has limited therapeutic options. left ventricular pressure overload leads to an increase in myocardial collagen content, causing left ventricular stiffening that contributes to the development of heart failure patients have a preserved left ventricular ejection fraction. Although several heart failure patients have a preserved left ventricular ejection fraction models have been developed in recent years to aid the investigation of mechanical alterations, none has investigated different phenotypes of the disease and evaluated the alterations in material properties. In this study, two similar healthy swine were subjected to progressive and prolonged pressure overload to induce diastolic heart failure characteristics, providing a preclinical model of heart failure patients have a preserved left ventricular ejection fraction. Cardiac magnetic resonance imaging (cMRI) scans and intracardiac pressures were recorded before and after induction. In both healthy and disease states, a corresponding finite element (FE) cardiac model was developed via mesh morphing of the Living Heart Porcine model. The material properties were derived by calibrating to its passive and active behavior. The change in the passive behavior was predominantly isotropic when comparing the geometries before and after induction. Myocardial thickening allowed for a steady transition in the passive properties while maintaining tissue incompressibility. This study highlights the importance of hypertrophy as an initial compensatory response and might also pave the way for assessing disease severity.
... This resistance parameter was chosen so that the peak pressure gradient between the ventricle and aorta during the open state of the valve is approximately 8 mmHg, as suggested in Mynard et al. (Mynard et al., 2012). Furthermore, the value for the outflow valve resistance used here is close to that used for the non-stenotic aortic valve case in Wisneski et al. (Wisneski et al., 2020). In general, variables from our baseline model match well with the clinical data. ...
Article
Full-text available
In this paper, we develop a pulsatile compartmental model of the Fontan circulation and use it to explore the effects of a fenestration added to this physiology. A fenestration is a shunt between the systemic and pulmonary veins that is added either at the time of Fontan conversion or at a later time for the treatment of complications. This shunt increases cardiac output and decreases systemic venous pressure. However, these hemodynamic benefits are achieved at the expense of a decrease in the arterial oxygen saturation. The model developed in this paper incorporates fenestration size as a parameter and describes both blood flow and oxygen transport. It is calibrated to clinical data from Fontan patients, and we use it to study the impact of a fenestration on several hemodynamic variables, including systemic oxygen availability, effective oxygen availability, and systemic venous pressure. In certain scenarios corresponding to high-risk Fontan physiology, we demonstrate the existence of a range of fenestration sizes in which the systemic oxygen availability remains relatively constant while the systemic venous pressure decreases.
Preprint
Transcatheter aortic valve replacement (TAVR) has rapidly displaced surgical aortic valve replacement (SAVR). However, certain post-TAVR complications persist, with cardiac conduction abnormalities (CCA) being one of the major ones. The elevated pressure exerted by the TAVR stent onto the conduction fibers situated between the aortic annulus and the His bundle, in proximity to the atrioventricular (AV) node, may disrupt the cardiac conduction leading to the emergence of CCA. In his study, an in-silico framework was developed to assess the CCA risk, incorporating the effect of a dynamic beating heart and pre-procedural parameters such as implantation depth and preexisting cardiac asynchrony in the new onset of post-TAVR CCA. A self-expandable TAVR device deployment was simulated inside an electro-mechanically coupled beating heart model in five patient scenarios, including three implantation depths, and two preexisting cardiac asynchronies: (i) a right bundle branch block (RBBB) and (ii) a left bundle branch block (LBBB). Subsequently, several biomechanical parameters were analyzed to assess the post-TAVR CCA risk. The results manifested a lower cumulative contact pressure on the conduction fibers following TAVR for aortic deployment (0.018 MPa) compared to baseline (0.29 MPa) and ventricular deployment (0.52 MPa). Notably, the preexisting RBBB demonstrated a higher cumulative contact pressure (0.34 MPa) compared to the baseline and preexisting LBBB (0.25 MPa). Deeper implantation and preexisting RBBB cause higher stresses and contact pressure on the conduction fibers leading to an increased risk of post-TAVR CCA. Conversely, implantation above the MS landmark and preexisting LBBB reduces the risk.
Article
Full-text available
Aortic stenosis, hypertension, and left ventricular hypertrophy often coexist in the elderly, causing a detrimental mismatch in coupling between the heart and vasculature known as ventricular−vascular (VA) coupling. Impaired left VA coupling, a critical aspect of cardiovascular dysfunction in aging and disease, poses significant challenges for optimal cardiovascular performance. This systematic review aims to assess the impact of simulating and studying this coupling through computational models. By conducting a comprehensive analysis of 34 relevant articles obtained from esteemed databases such as Web of Science, Scopus, and PubMed until July 14, 2022, we explore various modeling techniques and simulation approaches employed to unravel the complex mechanisms underlying this impairment. Our review highlights the essential role of computational models in providing detailed insights beyond clinical observations, enabling a deeper understanding of the cardiovascular system. By elucidating the existing models of the heart (3D, 2D, and 0D), cardiac valves, and blood vessels (3D, 1D, and 0D), as well as discussing mechanical boundary conditions, model parameterization and validation, coupling approaches, computer resources and diverse applications, we establish a comprehensive overview of the field. The descriptions as well as the pros and cons on the choices of different dimensionality in heart, valve, and circulation are provided. Crucially, we emphasize the significance of evaluating heart−vessel interaction in pathological conditions and propose future research directions, such as the development of fully coupled personalized multidimensional models, integration of deep learning techniques, and comprehensive assessment of confounding effects on biomarkers.
Article
Background and objective: Assessing the severity of pulmonary regurgitation (PR) and identifying optimal clinically relevant indicators for its treatment is crucial, yet standards for quantifying PR remain unclear in clinical practice. Computational modelling of the heart is in the process of providing valuable insights and information for cardiovascular physiology research. However, the advancements of finite element computational models have not been widely applied to simulate cardiac outputs in patients with PR. Furthermore, a computational model that incorporates both the left ventricle (LV) and right ventricle (RV) can be valuable in assessing the relationship between left and right ventricular morphometry and septal motion in PR patients. To enhance our understanding of the effect of PR on cardiac functions and mechanical behaviour, we developed a human bi-ventricle model to simulate five cases with varying degrees of PR severity. Methods: This bi-ventricle model was built using a patient-specific geometry and a widely used myofibre architecture. The myocardial material properties were described by a hyperelastic passive constitutive law and a modified time-varying elastance active tension model. To simulate realistic cardiac functions and the dysfunction of the pulmonary valve in PR disease cases, open-loop lumped parameter models representing systemic and pulmonary circulatory systems were designed. Results: In the baseline case, pressures in the aorta and main pulmonary artery and ejection fractions of both the LV and RV were within normal physiological ranges reported in the literature. The end-diastolic volume (EDV) of the RV under varying degrees of PR was comparable to the reported cardiac magnetic resonance imaging data. Moreover, RV dilation and interventricular septum motion from the baseline to the PR cases were clearly observed through the long-axis and short-axis views of the bi-ventricle geometry. The RV EDV in the severe PR case increased by 50.3% compared to the baseline case, while the LV EDV decreased by 18.1%. The motion of the interventricular septum was consistent with the literature. Furthermore, ejection fractions of both the LV and RV decreased as PR became severe, with LV ejection fraction decreasing from 60.5% at baseline to 56.3% in the severe case and RV ejection fraction decreasing from 51.8% to 46.8%. Additionally, the average myofibre stress of the RV wall at end-diastole significantly increased due to PR, from 2.7±12.1 kPa at baseline to 10.9±26.5 kPa in the severe case. The average myofibre stress of the LV wall at end-diastole increased from 3.7±18.1 kPa to 4.3±20.3 kPa. Conclusions: This study established a foundation for the computational modelling of PR. The simulated results showed that severe PR leads to reduced cardiac outputs in both the LV and RV, clearly observable septum motion, and a significant increase in the average myofibre stress in the RV wall. These findings demonstrate the potential of the model for further exploration of PR.
Article
Full-text available
PurposeOptimal assessment of cardiovascular performance requires simultaneous measurement of load independent left ventricular (LV) contractility, arterial function and LV/arterial coupling. We aimed to demonstrate feasibility of non-invasive ventricular pressure–volume and aortic pressure-flow-impedance measurements using simultaneous arterial tonometry (AT) and cardiovascular magnetic resonance imaging (CMRI).Methods21 consecutive patients referred for CMRI were enrolled to undergo a simultaneous AT and CMRI protocol. A CMRI compatible AT apparatus provided aortic end-systolic pressure, taken to be equivalent to LV end-systolic pressure in the absence of aortic stenosis. CMRI provided LV volume and aortic flow at the time of pressure acquisition. Pressure–volume relationships were determined and correlated to traditional parameters of LV function including ejection fraction and circumferential strain. Aortic pressure-flow relationships were used to determine aortic characteristic impedance and systemic vascular resistance.ResultsSimultaneous AT and CMRI permitted measurement of LV end-systolic elastance, preload recruitable stroke work, arterial elastance, aortic characteristic impedance and systemic vascular resistance. Absolute values were within the expected range for our cohort, were highly reproducible and showed appropriately directed correlation to traditional parameters.Conclusion Non-invasive assessment of LV pressure–volume and aortic pressure-flow relationships are both feasible and reproducible using simultaneous AT and CMRI. Methods permit assessment of load independent LV contractility, arterial function and LV/arterial coupling from a single non-invasive diagnostic encounter.
Article
Full-text available
Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure that provides an effective alternative to open-heart surgical valve replacement for treating advanced calcific aortic valve disease patients. However, complications, such as valve durability, device migration, paravalvular leakage (PVL), and thrombogenicity may lead to increased overall post-TAVR morbidity and mortality. A series of numerical studies involving a self-expandable TAVR valve were performed to evaluate these complications. Structural studies were performed with finite element (FE) analysis, followed by computational fluid dynamics (CFD) simulations, and fluid–structure interaction (FSI) analysis. The FE analysis was utilized to study the effect of TAVR valve implantation depth on valve anchorage in the Living Heart Human Model, which is capable of simulating beating heart during repeated cardiac cycles. The TAVR deployment cases where no valve migration was observed were then used to calculate the post-deployment thrombogenic potential via CFD simulations. FSI analysis followed to further assess the post-deployment TAVR hemodynamic performance for different implantation depths. The deployed valves PVL, geometric and effective orifice areas, and the leaflets structural and flow stress magnitudes were compared to determine the device optimal landing zone. The combined structural and hemodynamic analysis indicated that with the TAVR valve deployed at an aft ventricle position an optimal performance was achieved in the specific anatomy studied. Given the TAVR’s rapid expansion to younger lower-risk patients, the comprehensive numerical methodology proposed here can potentially be used as a predictive tool for both procedural planning and valve design optimization to minimize the reported complications.
Article
Full-text available
Background Normal-flow low-gradient severe aortic stenosis (NF-LG-SAS), defined by aortic-valve area < 1cm², mean gradient < 40 mmHg and indexed stroke volume > 35 ml/m², is the most prevalent form of low-gradient aortic stenosis (AS). However, the true severity of AS and the management of NF-LG-SAS is controversial. The aim of this study was to evaluate the outcome of patients with NF-LG-SAS compared to patients with moderate AS (MAS), who are considered to be suitable for conservative management. Methods and results A total of 520 patients were included in this study: 154 with NF-LG-SAS and 366 with MAS (aortic-valve area between 1.0 and 1.3 cm²). On Cox multivariate analysis, after adjustment for covariates of prognostic importance, NF-LG-SAS patients did not exhibit an excess risk of mortality compared to MAS patients, under medical management (P = 0.45) and under medical and surgical management (P = 0.70), even after further adjustment for aortic-valve replacement (AVR) (P = 0.56). The 6-year cumulative incidence of AVR (performed in accordance with current guidelines) was comparable between the two groups (39 ± 4% for NF-LG-SAS and 35 ± 3% for MAS, P = 0.10). After propensity score matching (n = 226), NF-LG-SAS patients and MAS patients also had comparable outcomes under medical (P = 0.41), and under medical and surgical management (P = 0.52) (Fig. 1). Conclusions This study shows that NF-LG-SAS have a comparable outcome to that of MAS when AVR was performed during follow-up according to guidelines, mostly at the stage of high-gradient AS. Rigorous echocardiographic assessment to rule out measurement errors and close follow-up are essential in NF-LG-SAS to detect progression to true severe AS.
Article
Full-text available
Background Normal‐flow, low‐gradient severe aortic stenosis (NF‐LG‐SAS), defined by aortic valve area <1 cm2, mean gradient <40 mm Hg, and indexed stroke volume >35 mL/m2, is the most prevalent form of low‐gradient aortic stenosis (AS). However, the true severity of AS and the management of NF‐LG‐SAS are controversial. The aim of this study was to evaluate the outcome of patients with NF‐LG‐SAS compared with moderate AS (MAS) and with high‐gradient severe‐AS (HG‐SAS). Methods and Results A total of 154 patients with NF‐LG‐SAS, 366 with MAS (aortic valve area between 1.0 and 1.3 cm2), and 1055 with HG‐SAS were included. On multivariate analysis, after adjustment for covariates of prognostic importance, NF‐LG‐SAS patients did not exhibit an excess risk of mortality compared with MAS patients under medical management (hazard ratio=1.13 [95% CI, 0.82‐1.56]; P=0.45) and under medical and surgical management (hazard ratio 1.06 [95% CI, 0.79‐1.43]; P=0.70), even after further adjustment for aortic valve replacement (hazard ratio=1.09 [95% CI, 0.81‐1.48]; P=0.56). The 6‐year cumulative incidence of aortic valve replacement (performed in accordance with guidelines) was comparable between the 2 groups (39±4% for NF‐LG‐SAS and 35±3% for MAS, P=0.10). After propensity score matching (n=226), NF‐LG‐SAS and MAS patients also had comparable outcomes under medical (P=0.41) and under medical and surgical management (P=0.52). NF‐LG‐SAS had better outcomes than HG‐SAS patients (adjusted hazard ratio 1.84 [95% CI, 1.18‐2.88]; P<0.001). Conclusions This study shows that patients with NF‐LG‐SAS have a comparable outcome to those with MAS when aortic valve replacement is performed during follow‐up according to guidelines, mostly at the stage of HG‐SAS. Rigorous echocardiographic assessment to rule out measurement errors and close follow‐up are essential to detect progression to true severe AS in NF‐LG‐SAS.
Article
Full-text available
Aims In aortic stenosis (AS), there is poor association between symptoms and conventional markers of AS severity or left ventricular (LV) systolic function. This may reflect that symptoms arise from LV diastolic dysfunction or that aortic valve area (AVA) and transvalvular gradient do not reflect afterload. We aimed to study the impact of afterload (end-systolic wall stress [ESWS]) on the presence of symptoms in AS and to test whether symptoms are related to increased ESWS or LV remodelling. Methods and results In a prospective study, ESWS was estimated by measuring LV wall thickness from MRI and estimated LV end systolic pressure from echocardiographic mean gradient and systolic blood pressure in 78 patients with severe AS scheduled for aortic valve replacement and 91 patients with asymptomatic severe AS. Symptomatic patients had lower indexed AVA (0.40±0.11 vs 0.45±0.09 cm ² /m ² , p=0.009). They had undergone more extensive remodelling (MRI LV mass index [LVMi]: 85±24 vs 69±17 g/m ² , p<0.0001), had higher tricuspid regurgitant gradient (24±8 mm Hg vs 19 ± 7 mm Hg, p=0.0001) and poorer global longitudinal strain (−15.6±3.8 vs −19.9±3.2%, p<0.0001). ESWS was higher among symptomatic patients (96±51 vs 76±25 kdynes/cm ² , p=0.003). Multivariate logistic regression identified echocardiographic relative wall thickness, tricuspid gradient, mitral deceleration time, early diastolic strain rate, MRI LVMi, MRI LV end-diastolic volume index and ESWS as independently associated with being symptomatic. Conclusion ESWS can be estimated from multimodality imaging combining MRI and echocardiography. It is correlated with LV remodelling and neurohormonal activation and is independently associated with symptomatic status in AS.
Article
Heart failure (HF) is one of the leading causes of death worldwide. HF is associated with substantial microstructural remodeling, which is linked to changes in left ventricular geometry and impaired cardiac function. The role of myocardial remodeling in altering the mechanics of failing hearts remains unclear. Structurally-based constitutive modeling provides an approach to improve understanding of the relationship between biomechanical function and tissue organization in cardiac muscle during HF. In the present study, we used cardiac magnetic resonance imaging and extended-volume confocal microscopy to quantify the remodeling of left ventricular geometry and myocardial microstructure of healthy and spontaneously hypertensive rat hearts, at the ages of 12 months and 24 months. Passive cardiac mechanical function was characterized using left ventricular pressure-volume compliance measurements. We have developed a new structurally-based biomechanical constitutive equation built on parameters quantified directly from collagen distributions observed in confocal images of the myocardium. 3D left ventricular finite element models were constructed from subject-specific in vivo MRI data. The structurally-based constitutive equation was integrated into geometrically subject-specific finite element models of the hearts, and used to investigate the underlying mechanisms of ventricular dysfunction during HF. Using a single pair of material parameters for all hearts, we were able to produce compliance curves which reproduced all of the experimental compliance measurements. The value of this study is not limited to reproducing the mechanical behavior of healthy and diseased hearts, but it also provides important insights into the structure-function relationship of diseased myocardium that will help pave the way towards more effective treatments for HF.
Article
Purpose Patient-specific models of the heart can be used to improve the diagnosis of cardiac diseases, but practical application of these models can be impeded by the computational costs and numerical uncertainties of fitting mechanistic models to clinical measurements from individual patients. Reliable and efficient tuning of these models within clinically appropriate error bounds is a requirement for practical deployment in the time-constrained environment of the clinic. Methods We developed an optimization framework to tune parameters of patient-specific mechanistic models using routinely-acquired non-invasive patient data more efficiently than manual methods. We employ a hybrid particle swarm and pattern search optimization algorithm, but the framework can be readily adapted to use other optimization algorithms. Results We apply the proposed framework to tune full-cycle lumped parameter circulatory models using clinical data. We show that our framework can be easily adapted to optimize cross-species models by tuning the parameters of the same circulation model to four canine subjects. Conclusions This work will facilitate the use of biomechanics and circulatory cardiac models in both clinical and research environments by ameliorating the tedious process of manually fitting the parameters.
Article
We sought to calibrate mechanical properties of left ventricle (LV) based on 3D speckle tracking echocardiographic imaging data recorded from 16 segments defined by American Heart Association (AHA). The in vivo data were used to create finite element (FE) LV and biventricular (BV) models. The orientation of the fibers in the LV model was rule-based, but diffusion tensor magnetic resonance imaging (DT-MRI) data were used for the fiber directions in the BV model. A nonlinear fiber-reinforced constitutive equation was used to describe the passive behavior of the myocardium, whereas the active tension was described by a model based on tissue contraction (Tmax). Isight was used for optimization, which used Abaqus as the forward solver (Simulia, Providence, USA). The calibration of passive properties based on the end diastolic pressure volume relation (ED PVR) curve resulted in relatively good agreement (mean error = -0.04 ml). The difference between experimental and computational strains decreased after segmental strain metrics, rather than global metrics, were used for calibration: for the LV model, the mean difference reduced from 0.129 to 0.046 (circumferential) and from 0.076 to 0.059 (longitudinal); for the BV model, the mean difference nearly did not change in the circumferential direction (0.061) but reduced in the longitudinal direction from 0.076 to 0.055. The calibration of mechanical properties for myocardium can be improved using segmental strain metrics. The importance of realistic fiber orientation and geometry for modeling of the LV was shown.
Article
Objectives: This study sought to determine the prevalence of reduced contractility and uncompensated wall stress in patients with aortic stenosis (AS) with preserved or reduced left ventricular ejection fraction (LVEF) and their impact on survival. Background: LVEF in AS is determined not only by contractility but also by loading conditions. Methods: Patients with first diagnosis (time 0) of severe AS (aortic valve area [AVA]≤1 cm2) with prior echo study (-3±1 years) were identified. Contractility was evaluated by plotting midwall fractional shortening (mFS) against circumferential end-systolic wall stress (cESS), stratified by LVEF of 60% at time 0. The temporal changes (from -3 years to time 0) and prognostic value of LVEF, contractility, and wall stress were assessed. Results: Of 445 patients, 290 (65%) had LVEF ≥60% (median: 66% [interquartile range {IQR}: 63% to 69%]) and 155 patients (35%) had LVEF <60% (median: 47% [IQR: 34% to 55%]). Median AVA was 1.27 cm2 (IQR: 1.13 to 1.43 cm2) at -3 years and 0.90 cm2 (IQR: 0.83 to 0.96 cm2) at time 0. Decreased contractility was already present at -3 years (49 [17%] vs. 59 [38%]; LVEF ≥60% vs. <60%; p < 0.001) and became more prevalent at time 0 (69 [24%] vs. 106 [68%]; p < 0.001). Overall, wall stress was well controlled in both groups at -3 years (1 [0%] vs. 12 [8%]; p < 0.001) but deteriorated over time in patients with LVEF <60% (time 0: 0 [0%] vs. 26 [17%]; p < 0.001). During a median follow-up of 3.4 years, LVEF <60%, decreased contractility and high wall stress were associated with worse survival (p < 0.01 for all). Decreased contractility remained incremental to LVEF in patients with LVEF ≥60% (p < 0.01), but less so when LVEF was <60% (p = 0.11). Conclusions: In patients with severe AS, LVEF <60% is associated with a poor prognosis, being linked with decreased contractility and/or high wall stress. Decreased contractility is also present in a subset of patients with LVEF ≥60% and provides incremental prognostic value. These abnormalities already exist before AVA reaches 1.0 cm2.
Article
Ventricular–arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment possesses independent diagnostic and prognostic value and may be used to refine riskstratification and monitor therapeutic interventions. Traditionally, VAC is assessed by the non‐invasive measurement of the ratio of arterial (Ea) to ventricular end‐systolic elastance (Ees). With disease progression, both Ea and Ees may become abnormal and the Ea/Ees ratio may approximate its normal values. Therefore, the measurement of each component of this ratio or of novel more sensitive markers of myocardial (e.g. global longitudinal strain) and arterial function (e.g. pulse wave velocity) may better characterize VAC. In valvular heart disease, systemic arterial compliance and valvulo–arterial impedance have an established diagnostic and prognostic value and may monitor the effects of valve replacement on vascular and cardiac function. Treatment guided to improve VAC through improvement of both or each one of its components may delay incidence of heart failure and possibly improve prognosis in heart failure. In this consensus document, we describe the pathophysiology, the methods of assessment as well as the clinical implications of VAC in cardiac diseases and heart failure. Finally, we focus on interventions that may improve VAC and thus modify prognosis.